About James Boylan
Form D filings for Graviton BioScience from 2023 to 2024 list James Boylan as director.
James Boylan first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name James Boylan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Boylan works with at each company, as listed on that company's latest Form D.
Graviton BioScience Corp · Form D, Feb 14, 2024
SW
Samuel Waksal
Chief Executive Officer and director
BC
Bihua Chen
Director
JL
Jeremy Levin
Director
DM
David MacMillan
Director
SP
Stelios Papadopoulos
Director
RN
Ran Nussbaum
Director